Source: Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Collura, W. Carey, J. Dong, Y.S. Prakash, D. Wigle (Rochester, United States Of America). Regulation of microRNA-mRNA target pairs in a model of bronchopulmonary dysplasia. Eur Respir J 2012; 40: Suppl. 56, 1400

Member's Comments

No comment yet.

Related content which might interest you: Prediction of bronchopulmonary dysplasia Source: Annual Congress 2009 - Neonatal respiratory disorders Year: 2009 Late Breaking Abstract - The miR-34a/Pdgfra interaction can be targeted to correct defective alveolarization in experimental bronchopulmonary dysplasia Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017 Polymorphisms of ADRB2 gene and airway resistance in children with bronchopulmonary dysplasia Source: International Congress 2015 – Respiratory physiology in children: technical and clinical aspects Year: 2015 Deregulated SOX2 drives a migratory signature in a novel organotypic model of bronchial dysplasia Source: ERS Lung Science Conference 2017 Year: 2017 Urinary metabolomics identifies molecular signatures associated with bronchopulmonary dysplasia (BPD) and birth-term Source: Virtual Congress 2020 – Airway development in health and disease Year: 2020 Evolution of lung function in preterm infants with or without bronchopulmonary dysplasia Source: Annual Congress 2011 - New insights in paediatric respiratory physiology Year: 2011 Recombinant human (rh)IGF-1/rhIGFBP-3 for prevention of bronchopulmonary dysplasia. Source: International Congress 2017 – Infant lung disease: physiology, assessment and novel therapies  Year: 2017 Refinement of the hyperoxia-based experimental mouse model of bronchopulmonary dysplasia Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Prediction of lung function and lung density of young adults who had bronchopulmonary dysplasia Source: ERJ Open Res, 6 (4) 00157-2020; 10.1183/23120541.00157-2020 Year: 2020 Imbalanced type I TGF-β receptor signalling in the pulmonary vasculature: implications for the pathogenesis of bronchopulmonary dysplasia Source: Eur Respir J 2007; 30: Suppl. 51, 55s Year: 2007 Lung function abnormalities in infants developing bronchopulmonary dysplasia Source: Annual Congress 2010 - Paediatric and neonatal intensive care Year: 2010 Pathogenesis of bronchopulmonary dysplasia Source: Eur Respir Monogr 2021; 92: 50-67 Year: 2021 Transglutaminase 2: a new player in bronchopulmonary dysplasia? Source: Eur Respir J 2014; 44: 109-121 Year: 2014 Sensitivity and specificity of a CT scoring system for bronchopulmonary dysplasia and its relationship with lung function Source: Annual Congress 2010 - Paediatric and neonatal intensive care Year: 2010 Functional capacity in pre-term bronchopulmonary dysplasia Source: Annual Congress 2010 - Dysfunctional breathing, asthma and respiratory physiotherapy problems Year: 2010 Clinical analysis of premature newborns displaying bronchopulmonary dysplasia Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities Year: 2010 LSC - 2017 - Deregulated SOX2 drives a migratory signature in a novel organotypic model of bronchial dysplasia Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 P16 in bronchopulmonary dysplasia: Early determinant of respiratory disease? Source: International Congress 2017 – Postnatal lung growth and development Year: 2017 Research lung function for children with bronchopulmonary dysplasia in the past Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Long term management of bronchopulmonary dysplasia Source: ERS Webinar 2020: Long term management of bronchopulmonary dysplasia Year: 2020